Elevance Health, Inc. (NYSE:ELV) Sees Significant Growth in Short Interest

Elevance Health, Inc. (NYSE:ELV - Get Free Report) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 3,630,000 shares, a growth of 5.2% from the December 15th total of 3,450,000 shares. Approximately 1.6% of the shares of the company are sold short. Based on an average trading volume of 1,940,000 shares, the short-interest ratio is presently 1.9 days.

Analysts Set New Price Targets

Several research firms have recently commented on ELV. Mizuho reduced their price target on shares of Elevance Health from $585.00 to $505.00 and set an "outperform" rating for the company in a research report on Tuesday, November 5th. Royal Bank of Canada reduced their price target on shares of Elevance Health from $585.00 to $478.00 and set an "outperform" rating for the company in a research report on Friday, October 18th. TD Cowen reduced their price target on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating for the company in a research report on Monday, October 21st. Morgan Stanley reduced their price target on shares of Elevance Health from $643.00 to $551.00 and set an "overweight" rating for the company in a research report on Wednesday, October 23rd. Finally, Truist Financial reduced their price target on shares of Elevance Health from $520.00 to $480.00 and set a "buy" rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Elevance Health currently has an average rating of "Moderate Buy" and a consensus price target of $536.53.

Elevance Health Price Performance

ELV traded down $1.00 during trading on Monday, reaching $384.26. 2,696,400 shares of the company traded hands, compared to its average volume of 1,457,754. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.50 and a current ratio of 1.50. Elevance Health has a 12-month low of $362.21 and a 12-month high of $567.26. The firm has a fifty day simple moving average of $388.02 and a 200 day simple moving average of $466.18. The company has a market cap of $89.12 billion, a P/E ratio of 14.01, a PEG ratio of 1.08 and a beta of 0.84.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The company reported $8.37 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $9.66 by ($1.29). Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. The company had revenue of $44.72 billion for the quarter, compared to analysts' expectations of $43.47 billion. During the same period last year, the business earned $8.99 earnings per share. The company's quarterly revenue was up 5.3% compared to the same quarter last year. On average, equities analysts forecast that Elevance Health will post 32.96 EPS for the current year.

Institutional Investors Weigh In On Elevance Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Pathway Financial Advisers LLC boosted its position in shares of Elevance Health by 51,967.1% during the 3rd quarter. Pathway Financial Advisers LLC now owns 657,607 shares of the company's stock valued at $341,956,000 after acquiring an additional 656,344 shares during the last quarter. Stifel Financial Corp grew its holdings in shares of Elevance Health by 309.7% in the third quarter. Stifel Financial Corp now owns 713,027 shares of the company's stock valued at $370,794,000 after purchasing an additional 538,978 shares in the last quarter. International Assets Investment Management LLC grew its holdings in shares of Elevance Health by 85,533.1% in the third quarter. International Assets Investment Management LLC now owns 532,638 shares of the company's stock valued at $276,972,000 after purchasing an additional 532,016 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Elevance Health by 16.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,397,258 shares of the company's stock valued at $1,246,574,000 after purchasing an additional 334,552 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in shares of Elevance Health by 6.9% in the third quarter. Wellington Management Group LLP now owns 4,461,585 shares of the company's stock valued at $2,320,024,000 after purchasing an additional 286,905 shares in the last quarter. 89.24% of the stock is owned by hedge funds and other institutional investors.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.